MiNK Therapeutics, Inc. (INKT) has a market capitalization of $67.09M and trades at $13.51. The 52-week range is 6.34-76.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.6, Earnings Per Share (EPS) of $-2.93.
The stock has a beta of 0.35, operates in the Healthcare sector.
